NCT00023998: Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma |
|
|
| Completed | 2 | 80 | US | doxorubicin hydrochloride, ADM, ADR, Adria, Adriamycin PFS, Adriamycin RDF, cisplatin, CACP, CDDP, CPDD, DDP, methotrexate, amethopterin, Folex, methylaminopterin, Mexate, MTX, leucovorin calcium, CF, CFR, LV, filgrastim, G-CSF, Neupogen, therapeutic conventional surgery, radiation therapy, irradiation, radiotherapy, therapy, radiation, etoposide, EPEG, VP-16, VP-16-213, ifosfamide, Cyfos, Holoxan, IFF, IFX, IPP, trastuzumab, anti-c-erB-2, Herceptin, MOAB HER2, laboratory biomarker analysis | National Cancer Institute (NCI) | Metastatic Osteosarcoma | 11/05 | 05/07 | | |
